NOSTRIN: A Protein Involved in Nitric Oxide and Disease (G115677)

Target Name: NOSTRIN

NCBI ID: G115677

NOSTRIN

NOSTRIN: A Protein Involved in Nitric Oxide and Disease

NOSTRIN is a protein that plays a crucial role in the production of nitric oxide, a molecule that causes blood vessels to relax and widen, leading to increased blood flow to the body's tissues. In addition to its role in blood flow, nitric oxide also plays a key role in the regulation of the immune system and has been linked to a number of diseases, including heart disease, diabetes, and even cancer.

The NOSTRIN gene has four splice variants, which are different lengths of the gene's coding region. The most common variant is the one that codes for the protein known as NOS2, which is a key component of the endothelial cell's cell membrane. The NOS2 protein is responsible for producing nitric oxide by catalyzing the conversion of the amino acid L-arginine into nitric oxide.

Another splice variant of the NOSTRIN gene is the one that codes for the protein known as NOS3. NOS3 is similar to NOS2 in its structure and function, but is produced at a different location in the body. NOS3 is produced by the liver and is responsible for producing nitric oxide in the liver and bloodstream.

In addition to its role in nitric oxide production, NOSTRIN has also been shown to play a number of other roles in the body. For example, NOS2 has been shown to play a key role in the regulation of the immune system, specifically in the production of T-cells. Additionally, NOS2 has been shown to play a role in the regulation of the blood-brain barrier, which is responsible for controlling the movement of nutrients and waste into and out of the brain.

NOSTRIN has also been shown to be involved in a number of diseases, including heart disease, diabetes, and even cancer. For example, studies have shown that NOS2 is often reduced in patients with heart disease, and that inhibiting NOS2 has been shown to improve blood flow and reduce the risk of heart attack in these patients. Additionally, NOS2 has been shown to be involved in the regulation of blood sugar levels, and has been linked to the development of type 2 diabetes.

Given its involvement in a number of important processes in the body, it is not surprising that NOSTRIN has been identified as a potential drug target. Researchers are currently working to develop NOS2 and NOS3 inhibitors as treatments for a variety of conditions, including heart disease, diabetes, and cancer. These inhibitors have the potential to increase blood flow, lower blood pressure, and improve overall health and wellbeing.

In conclusion, NOSTRIN is a protein that plays a crucial role in the production of nitric oxide, a molecule that is important for a number of processes in the body. The NOSTRIN gene has four splice variants, with the most common variant coding for the protein known as NOS2. NOS2 and NOS3 are both involved in the production of nitric oxide, and have been shown to play a number of roles in the regulation of the immune system and other processes in the body. Given its involvement in a number of important processes in the body, NOSTRIN is a potential drug target and has the potential to revolutionize our understanding of the role of nitric oxide in health and disease.

Protein Name: Nitric Oxide Synthase Trafficking

Functions: Multivalent adapter protein which may decrease NOS3 activity by inducing its translocation away from the plasma membrane

The "NOSTRIN Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NOSTRIN comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets